SPECIAL REPORT
Use in pediatric-onset MS (POMS)
Efficacy and safety in an adult population
Safety during pregnancy
Management of older MS patients
Latest News
Early use and long-term safety of ofatumumab: highlights from ECTRIMS 2025
October 7, 2025ECTRIMS 2025 HIGHLIGHTS – SATURDAY, SEPTEMBER 27, 2025
September 27, 2025The 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis – 24-26 September 2025
The following summarizes some of the highlights from Day 3 of ECTRIMS 2025.
ECTRIMS 2025 HIGHLIGHTS – FRIDAY, SEPTEMBER 26, 2025
September 26, 2025The 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis – 24-26 September 2025
The following summarizes some of the highlights from Day 2 of ECTRIMS 2025.